Literature DB >> 20644159

Optic neuropathy in patients with glioblastoma receiving bevacizumab.

Marc C Chamberlain, Jeffrey Raizer, David Schiff, Jonathan H Sherman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20644159     DOI： 10.1212/WNL.0b013e3181e79567

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Late effects of cancer treatment: consequences for long-term brain cancer survivors.

Authors:  Montse Alemany; Roser Velasco; Marta Simó; Jordi Bruna
Journal:  Neurooncol Pract       Date:  2020-07-16

2.  Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.

Authors:  Thomas Hundsberger; Detlef Brügge; Paul M Putora; Patrik Weder; Johannes Weber; Ludwig Plasswilm
Journal:  J Neurooncol       Date:  2013-01-12       Impact factor: 4.130

Review 3.  Two Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life Issues.

Authors:  D Beverly Fu; Daniela Alexandru; Dana M Curticiu; Yao Fu; Daniela A Bota
Journal:  J Adv Pract Oncol       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.